Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke | Zendy

Etsuro Mori | Zendy; Kazuo Minematsu | Zendy; Jyoji Nakagawara | Zendy; Yasuhiro Hasegawa | Zendy; Shinji Nagahiro | Zendy; Yasushi Okada | Zendy; Thomas Truelsen | Zendy; Annika Lindstén | Zendy; Akira Ogawa | Zendy; Takenori Yamaguchi | Zendy

Open Access

Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke

Author(s) -

Etsuro Mori,

Kazuo Minematsu,

Jyoji Nakagawara,

Yasuhiro Hasegawa,

Shinji Nagahiro,

Yasushi Okada,

Thomas Truelsen,

Annika Lindstén,

Akira Ogawa,

Takenori Yamaguchi

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.009917

Subject(s) - medicine , tolerability , asymptomatic , placebo , stroke (engine) , adverse effect , anesthesia , clinical endpoint , surgery , randomized controlled trial , mechanical engineering , alternative medicine , pathology , engineering

This study investigated the safety and tolerability of desmoteplase administered within 3 to 9 hours after stroke symptoms onset in Japanese patients with acute ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research